David C. Cronin, J. Michael Millis – 16 September 2004

Arie Regev, Enrique Molina, Rosana Moura, Pablo A. Bejarano, Amr Khaled, Phillip Ruiz, Kris Arheart, Mariana Berho, Cinthia B. Drachenberg, Patricia Mendez, Christopher O'Brien, Lennox Jeffers, Andreas Tzakis, Eugene R. Schiff – 16 September 2004 – Histopathologic assessment is considered essential for the differentiation of recurrent hepatitis C (RHC) from acute cellular rejection (ACR) after liver transplantation (LT); however, there is limited information regarding its reliability.

Peter L. Abt, Rachel Rapaport‐Kelz, Niraj M. Desai, Adam Frank, Seema Sonnad, Elizabeth Rand, James F. Markmann, Abraham Shaked, Kim M. Olthoff – 16 September 2004 – Segmental liver transplantation with living donor (LD), reduced cadaveric (Reduced), and split cadaveric (Split) allografts has expanded the availability of size‐appropriate organs for pediatric recipients. The relevance of recipient age to the selection of graft type has not been fully explored, but could offer the potential to maximize recipient outcome and donor utilization.

Paul Martin, Ronald W. Busuttil, Robert M. Goldstein, Jeffrey S. Crippin, Goran B. Klintmalm, William E. Fitzsimmons, Carol Uleman – 16 September 2004 – Hepatitis C virus (HCV)‐induced cirrhosis is the commonest indication for orthotopic liver transplantation, but HCV recurrence is nearly universal and may worsen patient / graft outcomes. The frequency and severity of HCV recurrence has apparently increased in recent years, raising concern about a possible role for newer immunosuppression regimens in this increase, including potentially tacrolimus.

Todd A. Sheer, Bruce A. Runyon – 16 September 2004

Norman M. Kneteman, José Oberholzer, Mohammed Al Saghier, Glenda A. Meeberg, Maurice Blitz, Mang M. Ma, Winnie W.S. Wong, Klaus Gutfreund, Andrew L. Mason, Larry D. Jewell, A.M. James Shapiro, Vincent G. Bain, David L. Bigam – 16 September 2004 – An increasing number of patients with hepatocellular carcinoma (HCC) are undergoing evaluation for listing for liver transplantation. Criteria for selection require ongoing review for suitability.

Margarita Sala, Josep Fuster, Josep M. Llovet, Miquel Navasa, Manel Solé, María Varela, Fernando Pons, Antoni Rimola, Juan Carlos García‐Valdecasas, Concepció Brú, Jordi Bruix – 16 September 2004 – Surgical resection and liver transplantation offer a 5‐year survival greater than 70% in patients with hepatocellular carcinoma, but the high recurrence rate impairs long‐term outcome after resection. Pathological data such as vascular invasion and detection of additional nodules predict recurrence and divide patients into high and low risk profile.

Paul J. Thuluvath, Hwan Y. Yoo – 16 September 2004 – Live donor liver transplantation (LDLT) has become increasingly common in the United States and around the world. In this study, we compared the outcome of 764 patients who received LDLT in the United States and compared the results with a matched population that received deceased donor transplantation (DDLT) using the United Network for Organ Sharing (UNOS) database.

Robert A. Fisher – 16 September 2004

Brendan C. Visser, Insoo Suh, Shinjiro Hirose, Philip Rosenthal, Hanmin Lee, John P. Roberts, Ryutaro Hirose – 16 September 2004 – After portoenterostomy (PE) for biliary atresia (BA), many patients suffer progressive deterioration of liver function and ultimately require liver transplantation. We retrospectively reviewed a single center's experience with pediatric liver transplantation for BA from 1988 to 2002. Sixty‐six patients underwent 69 liver transplants for BA.